Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Nov 1;166(5):1259–1279. doi: 10.1084/jem.166.5.1259

Suggested mechanism for the selective excretion of glucosylated albumin. The effects of diabetes mellitus and aging on this process and the origins of diabetic microalbuminuria

PMCID: PMC2189662  PMID: 3119757

Abstract

In previous studies in the Sprague-Dawley rat, Williams and coworkers reported the phenomenon of selective urinary excretion of glucosylated albumin (editing, i.e., the percent glucosylation of urinary albumin is more than that of plasma albumin) by the mammalian kidney. Ghiggeri and coworkers subsequently found that the extent of editing is reduced in human diabetics. Moreover, the reduction in editing in diabetes correlates inversely with levels of microalbuminuria. We also find reduction in the extent of editing in diabetic humans. We find a striking inverse correlation not only with the magnitude of microalbuminuria but also with the extent of plasma albumin glucosylation. In contrast, we found little correlation between the reduction in editing and the duration of diabetes in human subjects. Stz induced diabetes in the Sprague-Dawley rat is associated with a striking and rapid reduction in editing which develops virtually with the same kinetics exhibited by the appearance of hyperglycemia. This loss of editing is rapidly reversed by daily administration of insulin but not by aldose reductase inhibitors. Mannitol infusion in anesthetized Wistar rats resulted in an increase in urine volume, GFR, and microalbuminuria, and was also accompanied by a marked reduction in editing. This reduction was rapidly reversed by a cessation of mannitol infusion. We propose here that glucosylated albumin (in contrast to unmodified albumin) is not reabsorbed by the proximal tubule, and thus, is preferentially excreted in the urine. We postulate that the increase in GFR which emerges as a consequence of increased plasma osmolality in diabetes mellitus delivers more albumin to the proximal tubule than can be reabsorbed. This results in a dilution of excreted glucosylated albumin molecules by excreted unmodified albumin, which appears as the early microscopic albuminuria of diabetes. Paradoxically, the fall in apparent editing is accompanied by an absolute increase in the total quantity of glucosylated albumin excreted. In contrast, we found that editing of glucosylated albumin by the normal kidney is found to gradually decline as a function of age without the appearance of microalbuminuria. This suggests that a different mechanism operates to produce the loss of editing seen with aging in man, and as clearly (but in a shorter absolute time intervals) in the Fischer-344 rat.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beyer T. A., Hutson N. J. Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications. Metabolism. 1986 Apr;35(4 Suppl 1):1–3. doi: 10.1016/0026-0495(86)90178-2. [DOI] [PubMed] [Google Scholar]
  2. Bourdeau J. E., Carone F. A. Protein handling by the renal tubule. Nephron. 1974;13(1):22–34. doi: 10.1159/000180367. [DOI] [PubMed] [Google Scholar]
  3. Brenner B. M., Hostetter T. H., Humes H. D. Molecular basis of proteinuria of glomerular origin. N Engl J Med. 1978 Apr 13;298(15):826–833. doi: 10.1056/NEJM197804132981507. [DOI] [PubMed] [Google Scholar]
  4. Brownlee M., Cerami A. The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem. 1981;50:385–432. doi: 10.1146/annurev.bi.50.070181.002125. [DOI] [PubMed] [Google Scholar]
  5. Bunn H. F. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med. 1981 Feb;70(2):325–330. doi: 10.1016/0002-9343(81)90769-5. [DOI] [PubMed] [Google Scholar]
  6. Candiano G., Ghiggeri G. M., Delfino G., Cavatorta F., Queirolo C. Determination of a glycosyl subunit of human serum albumin by concanavalin A-sepharose. Clin Chim Acta. 1983 Feb 28;128(1):29–40. doi: 10.1016/0009-8981(83)90052-9. [DOI] [PubMed] [Google Scholar]
  7. Christensen E. I., Carone F. A., Rennke H. G. Effect of molecular charge on endocytic uptake of ferritin in renal proximal tubule cells. Lab Invest. 1981 Apr;44(4):351–358. [PubMed] [Google Scholar]
  8. Clements R. S., Jr Diabetic neuropathy--new concepts of its etiology. Diabetes. 1979 Jun;28(6):604–611. doi: 10.2337/diab.28.6.604. [DOI] [PubMed] [Google Scholar]
  9. DAVIES D. F., SHOCK N. W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507. doi: 10.1172/JCI102286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Day J. F., Thornburg R. W., Thorpe S. R., Baynes J. W. Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo. J Biol Chem. 1979 Oct 10;254(19):9394–9400. [PubMed] [Google Scholar]
  11. Evan-Wong L. A., Davidson R. J. Raised Coulter mean corpuscular volume in diabetic ketoacidosis, and its underlying association with marked plasma hyperosmolarity. J Clin Pathol. 1983 Mar;36(3):334–336. doi: 10.1136/jcp.36.3.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. FETERIS W. A. A SERUM GLUCOSE METHOD WITHOUT PROTEIN PRECIPITATION. Am J Med Technol. 1965 Jan-Feb;31:17–21. [PubMed] [Google Scholar]
  13. First M. R., Sloan D. E., Pesce A. J., Pollak V. E. Albumin excretion by the kidney: the effects of volume expansion. J Lab Clin Med. 1977 Jan;89(1):25–29. [PubMed] [Google Scholar]
  14. Garlick R. L., Mazer J. S. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983 May 25;258(10):6142–6146. [PubMed] [Google Scholar]
  15. Ghiggeri G. M., Candiano G., Delfino G., Bianchini F., Queirolo C. Glycosyl albumin and diabetic microalbuminuria: demonstration of an altered renal handling. Kidney Int. 1984 Mar;25(3):565–570. doi: 10.1038/ki.1984.55. [DOI] [PubMed] [Google Scholar]
  16. Ghiggeri G. M., Candiano G., Delfino G., Queirolo C. Electrical charge of serum and urinary albumin in normal and diabetic humans. Kidney Int. 1985 Aug;28(2):168–177. doi: 10.1038/ki.1985.137. [DOI] [PubMed] [Google Scholar]
  17. Gonzalez A. M., Sochor M., McLean P. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats. Diabetes. 1983 May;32(5):482–485. doi: 10.2337/diab.32.5.482. [DOI] [PubMed] [Google Scholar]
  18. Heinegård D., Tiderström G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973 Feb 12;43(3):305–310. doi: 10.1016/0009-8981(73)90466-x. [DOI] [PubMed] [Google Scholar]
  19. Kador P. F., Akagi Y., Kinoshita J. H. The effect of aldose reductase and its inhibition on sugar cataract formation. Metabolism. 1986 Apr;35(4 Suppl 1):15–19. doi: 10.1016/0026-0495(86)90181-2. [DOI] [PubMed] [Google Scholar]
  20. Kanwar Y. S., Rosenzweig L. J., Linker A., Jakubowski M. L. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2272–2275. doi: 10.1073/pnas.80.8.2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kerjaschki D., Sharkey D. J., Farquhar M. G. Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol. 1984 Apr;98(4):1591–1596. doi: 10.1083/jcb.98.4.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kolta M. G., Wallace L. J., Gerald M. C. Streptozocin-induced diabetes affects rat urinary bladder response to autonomic agents. Diabetes. 1985 Sep;34(9):917–921. doi: 10.2337/diab.34.9.917. [DOI] [PubMed] [Google Scholar]
  23. Laguens R. P., Candela S., Hernández R. E., Gagliardino J. J. Streptozotocin-induced liver damage in mice. Horm Metab Res. 1980 May;12(5):197–201. doi: 10.1055/s-2007-996241. [DOI] [PubMed] [Google Scholar]
  24. MARSHALL M. E., DEUTSCH H. F. Clearances of some proteins by the dog kidney. Am J Physiol. 1950 Nov;163(2):461–467. doi: 10.1152/ajplegacy.1950.163.2.461. [DOI] [PubMed] [Google Scholar]
  25. MacFarlane M., Skett P. Time course of the effect of streptozotocin on serum concentration of glucose and triglycerides and on hepatic drug metabolism in the male rat. Acta Endocrinol (Copenh) 1986 Jun;112(2):300–304. doi: 10.1530/acta.0.1120300. [DOI] [PubMed] [Google Scholar]
  26. Miller K., Michael A. F. Immunopathology of renal extracellular membranes in diabetes mellitus. Specificity of tubular basement-membrane immunofluorescence. Diabetes. 1976 Aug;25(8):701–708. doi: 10.2337/diab.25.8.701. [DOI] [PubMed] [Google Scholar]
  27. Mogensen C. E. Renal function changes in diabetes. Diabetes. 1976;25(2 Suppl):872–879. [PubMed] [Google Scholar]
  28. Morris M. A., Preddy L. Glycosylation accelerates albumin degradation in normal and diabetic dogs. Biochem Med Metab Biol. 1986 Jun;35(3):267–270. doi: 10.1016/0885-4505(86)90082-4. [DOI] [PubMed] [Google Scholar]
  29. Parthasarathy N., Spiro R. G. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes. 1982 Aug;31(8 Pt 1):738–741. doi: 10.2337/diab.31.8.738. [DOI] [PubMed] [Google Scholar]
  30. Solomon S. Maximal gradients of na and k across proximal tubules of kidneys of immature rats. Biol Neonate. 1974;25(5-6):327–339. doi: 10.1159/000240706. [DOI] [PubMed] [Google Scholar]
  31. Steinitz K., Türkand H. THE DETERMINATION OF THE GLOMERULAR FILTRATION BY THE ENDOGENOUS CREATININE CLEARANCE. J Clin Invest. 1940 Mar;19(2):285–298. doi: 10.1172/JCI101131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stiles J. W., Francendese A. A., Masoro E. J. Influence of age on size and number of fat cells in the epididymal depot. Am J Physiol. 1975 Dec;229(6):1561–1568. doi: 10.1152/ajplegacy.1975.229.6.1561. [DOI] [PubMed] [Google Scholar]
  33. Travis J., Bowen J., Tewksbury D., Johnson D., Pannell R. Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J. 1976 Aug 1;157(2):301–306. doi: 10.1042/bj1570301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Viberti G., Keen H. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes. 1984 Jul;33(7):686–692. doi: 10.2337/diab.33.7.686. [DOI] [PubMed] [Google Scholar]
  35. Vlassara H., Brownlee M., Cerami A. Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes. 1985 Jun;34(6):553–557. doi: 10.2337/diab.34.6.553. [DOI] [PubMed] [Google Scholar]
  36. Westberg N. G. Biochemical alterations of the human glomerular basement membrane in diabetes. Diabetes. 1976;25(2 Suppl):920–924. [PubMed] [Google Scholar]
  37. Westberg N. G., Michael A. F. Immunohistopathology of diabetic glomerulosclerosis. Diabetes. 1972 Mar;21(3):163–174. doi: 10.2337/diab.21.3.163. [DOI] [PubMed] [Google Scholar]
  38. Williams S. K., Devenny J. J., Bitensky M. W. Micropinocytic ingestion of glycosylated albumin by isolated microvessels: possible role in pathogenesis of diabetic microangiopathy. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2393–2397. doi: 10.1073/pnas.78.4.2393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Williams S. K., Howarth N. L., Devenny J. J., Bitensky M. W. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6546–6550. doi: 10.1073/pnas.79.21.6546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Woo J., Floyd M., Cannon D. C., Kahan B. Radioimmunoassay for urinary albumin. Clin Chem. 1978 Sep;24(9):1464–1467. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES